Functional characteristics of neutrophils collected and stored after administration of G-CSF

Transfusion

Volumn 40, Issue 4, 2000, Pages 414-419

  Leavey, P J ^b   Thurman, G ^b   Ambruso, Daniel R ^a  

^a Bonfils Blood Center   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

GRANULOCYTE COLONY STIMULATING FACTOR; MEMBRANE PROTEIN; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE;

APHERESIS; ARTICLE; BLOOD STORAGE; CELL FREE SYSTEM; CELL ISOLATION; ENZYME ACTIVITY; GRANULOCYTE TRANSFUSION; HUMAN; HUMAN CELL; NEUTROPENIA; NEUTROPHIL CHEMOTAXIS;

ADULT; BLOOD SPECIMEN COLLECTION; BLOTTING, WESTERN; CHEMOTAXIS, LEUKOCYTE; CYTOCHROME B GROUP; GRANULOCYTE COLONY-STIMULATING FACTOR; HUMANS; NADPH OXIDASE; NEUTROPHILS; SUBCELLULAR FRACTIONS;

EID: 0007111602     PISSN: 00411132     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1537-2995.2000.40040414.x     Document Type: Article

References (46)

1. Strauss RG. Granulocyte transfusion therapy. Hematol Oncol Clin North Am 1994:8:1159-66.
2. Alavi JB, Root RK, Djerassi I, et al. A randomized clinical trial of granulocyte transfusions for infection in acute leukemia. N Engl J Med 1977;296:706-11.
3. Graw RG Jr, Herzig G, Perry S, Henderson ES. Normal granulocyte transfusion therapy: treatment of septicemia due to gram-negative bacteria. N Engl J Med 1972:287:367-71.
4. Higby DJ, Yates JW, Henderson ES, Holland JF. Filtration leukapheresis for granulocyte transfusion therapy. Clinical and laboratory studies. N Engl J Med 1975:292:761-6.
5. Vogler WR, Winton EF. A controlled study of the efficacy of granulocyte transfusions in patients with neutropenia. Am J Med 1977:63:548-55.
6. Herzig RH, Herzig GP, Graw RG Jr, et al. Successful granulocyte transfusion therapy for gram-negative septicemia. A prospectively randomized controlled study. N Engl J Med 1977:296:701-5.
7. Strauss RG. Neutrophil (granulocyte) transfusions in the new millennium (editorial). Transfusion 1998:38:710-2.
8. Hester JP, Dignani MC, Anaissie EJ, et al. Collection and transfusion of granulocyte concentrates from donors primed with granulocyte stimulating factor and response of myelosuppressed patients with established infection. J Clin Apheresis 1995:10:188-93.
9. Lane TA. Granulocyte storage. Transfus Med Rev 1990:4:23-34.
10. Winston DJ, Ho WG, Gale RP. Therapeutic granulocyte transfusions for documented infections. A controlled trial in ninety-five infectious granulocytopenic episodes. Ann Intern Med 1982:97:509-15.
11. Fortuny IE, Bloomfield CD, Hadlock DC, et al. Granylocyte transfusion: a controlled study in patients with acute nonlymphocytic leukemia. Transfusion 1975:15:548-58.
12. Curnutte JT. Disorders of granulocyte function and granulopoiesis. In: Nathan DG, Oski FA, eds. Hematology of infancy and childhood. Philadelphia: WB Saunders, 1993:904-77.
13. Schiffer CA. Granulocyte transfusions: an overlooked therapeutic modality. Transfus Med Rev 1990:4:2-7.
14. Bensinger WI, Price TH, Dale DC, et al. The effects of daily recombinant human granulocyte colony-stimulating factor administration on normal granulocyte donors undergoing leukapheresis. Blood 1993;81:1883-8.
15. Ambruso DR, Brentwood B, Henson PM, Johnston RB Jr. Oxidative metabolism of cord blood neutrophils: relationship to content and degranulation of cytoplasmic granules. Pediatr Res 1984:18:1148-53.
16. Maderazo EG, Ward PA. Leukocyte chemotaxis. In: Rose NR, Friedman NH, Fahey JL, eds. Manual of clinical immunology. Washington, DC: American Society for Microbiology, 1986:290-4.
17. Harbeck RJ, Giclas PC. Diagnostic immunology laboratory manual. New York: Raven Press, 1991:223-77.
18. Rosenthal J, Thurman GW, Cusack N, et al. Neutrophils from patients after burn injury express a deficiency of the oxidase components p47-phox and p67-phox. Blood 1996:88:4321-9.
19. Ambruso DR, Stork LC, Gibson BE, Thurman GW. Increased activity of the respiratory burst in cord blood neutrophils: kinetics of the NADPH oxidase enzyme system in subcellular fractions. Pediatr Res 1987:21:205-10.
20. Leavey PJ, Sellins KS, Thurman G, et al. In vivo treatment with granulocyte colony stimulating factor results in divergent effects on neutrophil functions measured in vitro. Blood 1998:92:4366-74.
21. 2 oxidoreductase in human neutrophils after stimulation with phorbol myristate acetate. J Biol Chem 1990;265:924-30.
22. Cole JW, Grizzle JE. Applications of multivariate analysis of variance to repeated measurements experiments. Biometrics 1966:22:810-28.
23. Dale DC, Liles WC, Llewellyn C, et al. Neutrophil transfusions: kinetics and functions of neutrophils mobilized with granulocyte-colony-stimulating factor and dexamethasone. Transfusion 1998;38:713-21.
24. Jendiroba DB, Lichtiger B, Anaissie E, et al. Evaluation and comparison of three mobilization methods for the collection of granulocytes. Transfusion 1998:38:722-8.
25. Nicola NA. Granulocyte colony stimulating factor. In: Dexter TM, Garland JM, Testa NG, eds. Colony-stimulating factors. New York: Marcel Dekker, 1990:77-109.
26. Sullivan GW, Carper HT, Mandell GL. The effect of three human recombinant hematopoietic growth factors (granulocyte-macrophage colony-stimulating factor, granulocyte colony-stimulating factor, and interleukin-3) on phagocyte oxidative activity. Blood 1993;81:1863-70.
27. Sato N, Asano S, Koeffler HP, et al. Identification of neutrophil alkaline phosphatase-inducing factor in cystic fluid of a human squamous cell carcinoma as granulocyte colony-stimulating factor. J Cell Physiol 1988:137:272-6.
28. Fossat C, Stoppa AM, Sainty D, et al. G-CSF in vivo improves neutrophils bactericidal activity against Pseudomonas aeruginosae in cancer patients (abstract). Blood 1990;76:144a.
29. Liles WC, Huang JE, van Burik JH, et al. Granulocyte colony-stimulating factor administered in vivo augments neutrophil-mediated activity against opportunistic fungal pathogens. J Infect Dis 1997;175:1012-5.
30. Price TH, Chatta GS, Dale DC. Effect of recombinant granulocyte colony-stimulating factor on neutrophil kinetics in normal young and elderly humans. Blood 1996;88:335-40.
31. Spiekermann K, Roesler J, Emmendoerffer A, et al. Functional features of neutrophils induced by G-CSF and GM-CSF treatment: differential effects and clinical implications. Leukemia 1997:11:466-78.
32. Leavey PJ, Thurman G, Gonzalez-Aller C, et al. The effects of stem cell factor and granulocyte colony stimulating factor therapy on the activity of the neutrophil NADPH oxidase enzyme system. J Invest Med 1998:46:121-6.
33. Gottlieb RA, Giesing HA, Zhu JY, et al. Cell acidification in apoptosis: granulocyte colony-stimulating factor delays programmed cell death in neutrophils by up-regulating the vacuolar H(+)-ATPase. Proc Natl Acad Sci U S A 1995:92:5965-8.
34. Squier MK, Sehnert AJ, Cohen JJ. Apoptosis in leukocytes. J Leukoc Biol 1995:57:2-10.
35. Linch DC, Scarffe H, Proctor S, et al. Randomized vehicle-controlled dose-finding study of glycosylated recombinant human granulocyte colony-stimulating factor after bone marrow transplantation. Bone Marrow Transplant 1993:11:307-11.
36. Glaspy JA, Bleecker G, Crawford J, et al. The impact of therapy with filgrastim (recombinant granulocyte colony-stimulating factor) on the health care costs associated with cancer chemotherapy. Eur J Cancer 1993;29A(Suppl 7):S23-S30.
37. Kaposzta R, Marodi L. Chronic neutropenia and defect in Superoxide generation of granulocytes in two patients: enhancement of bactericidal capacity and respiratory burst activity by treatment with recombinant human granulocyte colony-stimulating factor. Pediatr Res 1995;37:50-5.
38. Schroten H, Roesler J, Breidenbach T, et al. Granulocyte and granulocyte-macrophage colony-stimulating factors for treatment of neutropenia in glycogen storage disease type Ib. J Pediatr 1991;119:748-54.
39. Welte K, Gabrilove J, Bronchud MH, et al. Filgrastim (r-metHuG-CSF): the first 10 years. Blood 1996:88:1907-29.
40. Wikman A, Lundahl J, Fernvik E, Shanwell A. Altered expression of adhesion molecules (L-selectin and Mac-1) on granulocytes during storage. Transfusion 1994:34:167-71.
41. Humbert JR, Fermin CD, Winsor EL. Early damage to granulocytes during storage. Semin Hematol 1991:28:10-3.
42. Rex JH, Bhalla SC, Cohen DM, et al. Protection of human polymorphonuclear leukocyte function from the deleterious effects of isolation, irradiation, and storage by inter-feron-yand granulocyte-colony-stimulating factor. Transfusion 1995:35:605-11.
43. Murea S, Fruehauf S, Zeller WJ, Haas R. Granulocytes harvested following G-CSF-enhanced leukocyte recovery retain their functional capacity during in vitro culture for 72 hours. J Hematother 1996:5:351-7.
44. Khwaja A, Carver JE, Linch DC. Interactions of granulocyte-macrophage colony-stimulating factor (CSF), granulocyte CSF, and tumor necrosis factor alpha in the priming of the neutrophil respiratory burst. Blood 1992:79:745-53
45. Balazovich KJ, Almeida HI, Boxer LA. Recombinant human G-CSF and GM-CSF prime human neutrophils for superoxide production through different signal transduction mechanisms. J Lab Clin Med 1991:118:576-84.
46. Stroncek DF, Leitman SF, Fall in pH accompanies storage of granulocyte colony-stimulating factor (G-CSF) -mobilized granulocyte concentrates (abstract). Blood 1998;92:53a